Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanomedic Technologies Ltd. is active in the Chemistry & Materials technology area. The company's patent portfolio currently includes 1 pending office action. This action is being reviewed by 1 distinct examiner and is located within 1 distinct art unit. This concentration suggests a focused approach to its current patent filings.
The busiest examiner for Nanomedic Technologies Ltd. is LIU, XUE H, who is managing 1 busiest examiner pending office action. Because the total count of 1 pending office action is assigned to this individual, LIU, XUE H is the only examiner currently reviewing the company's applications. The presence of 1 distinct art unit indicates that the technical subject matter of the pending action falls within a specific chemical or material science category. For practitioners, this means the current prosecution strategy is highly dependent on the interactions with a single examiner and the standards of 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, XUE H | 1 | 73.1% | +12.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18435004 | PRODUCING A COMBINED MATRIX AND CELLS IN SITU ON A DAMAGED TISSUE AND APPARATUS FOR IMPLEMENTING THE SAME | LIU, XUE H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18435004 | PRODUCING A COMBINED MATRIX AND CELLS IN SITU ON A DAMAGED TISSUE AND APPARATUS FOR IMPLEMENTING THE SAME | LIU, XUE H | — |
| Art Unit | Apps |
|---|---|
| 1742 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18435004 | PRODUCING A COMBINED MATRIX AND CELLS IN SITU ON A DAMAGED TISSUE AND APPARATUS FOR IMPLEMENTING THE SAME | LIU, XUE H | 1742 | §102§103 | Final Rejection | — | Pending | Feb 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanomedic Technologies Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Xue H Liu has the most, with 1 of Nanomedic Technologies Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
